Republished from Press Information Bureau
Medicines and Devices · Uttar Pradesh
Indian Pharmacopoeia Commission Signs MoU with Uttar Pradesh Promote Pharma Council (UPPPC) to Strengthen Quality, Innovation, and Regulatory Excellence in Healthcare
Full text of a press release issued by the Ministry of Health and Family Welfare through the Press Information Bureau on 15 July 2026.
In a major step towards advancing high-quality healthcare standards and strengthening the regulatory framework, the Indian Pharmacopoeia Commission (IPC) signed a Memorandum of Understanding (MoU) with the Uttar Pradesh Promote Pharma Council (UPPPC). The MoU was signed during the YEIDA MedTech Investors Meet & Site Visit 2026, held on 14 July 2026 at the India Expo Mart, Greater Noida.
This strategic collaboration aims to strengthen the pharmaceutical and medical device ecosystem by promoting quality standards, regulatory excellence, innovation, and capacity building across the sector.
Through this partnership, IPC and UPPPC will work together to:
• Strengthen quality standards and regulatory compliance in the pharmaceutical and medical device industries.
• Promote awareness of the Indian Pharmacopoeia, pharmacovigilance, and materiovigilance.
• Organize joint training programmes, workshops, and stakeholder awareness initiatives.
• Foster research, innovation, and industry–academia collaborations.
• Support MSMEs by providing digital tools for adverse event reporting
• Enhance patient safety through quality assurance and post-market surveillance initiatives.
This MoU reflects IPC's continued commitment to advancing high-quality healthcare standards, supporting innovation, and strengthening India's regulatory framework while contributing to the growth of Uttar Pradesh as a leading hub for pharmaceuticals, medical devices, and healthcare technologies.
The partnership strives to build a stronger ecosystem that promotes quality, safety, innovation, and global competitiveness.
Sources
Related reports
Republished from Press Information Bureau
Union Ministry of Health Proposes Incorporation of Good Storage and Distribution Practices into Drugs Rules, 1945
Full text of a press release issued by the Ministry of Health and Family Welfare through the Press Information Bureau on 19 November 2026.
Republished from Press Information Bureau
Union Health Ministry Proposes Amendment to Drugs Rules, 1945 to Provide Regulatory Flexibility for Medicinal Gases, Empty Gelatin Capsules and Disinfectant Fluids
Full text of a press release issued by the Ministry of Health and Family Welfare through the Press Information Bureau on 19 November 2026.
Republished from Press Information Bureau
Union Health Ministry Proposes Amendment to New Drugs and Clinical Trials Rules, 2019 to Bring Antimicrobials under Central Regulatory Oversight
Full text of a press release issued by the Ministry of Health and Family Welfare through the Press Information Bureau on 19 November 2026.
Republished from Press Information Bureau
Union Ministry of Health Proposes Separate Licensing Framework for Wholesale of Bulk Drugs
Full text of a press release issued by the Ministry of Health and Family Welfare through the Press Information Bureau on 19 November 2026.